======= PPP1R16B =======
== Gene Information ==
* **Official Symbol**: PPP1R16B
* **Official Name**: protein phosphatase 1 regulatory subunit 16B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26051|26051]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96T49|Q96T49]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PPP1R16B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPP1R16B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613275|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Regulator of protein phosphatase 1 (PP1) that acts as a positive regulator of pulmonary endothelial cell (EC) barrier function (PubMed:18586956). Involved in the regulation of the PI3K/AKT signaling pathway, angiogenesis and endothelial cell proliferation (PubMed:25007873). Regulates angiogenesis and endothelial cell proliferation through the control of ECE1 dephosphorylation, trafficking and activity (By similarity). Protects the endothelial barrier from lipopolysaccharide (LPS)- induced vascular leakage (By similarity). Involved in the regulation of endothelial cell filopodia extension (By similarity). May be a downstream target for TGF-beta1 signaling cascade in endothelial cells (PubMed:16263087, PubMed:18586956). Involved in PKA-mediated moesin dephosphorylation which is important in EC barrier protection against thrombin stimulation (PubMed:18586956). Promotes the interaction of PPP1CA with RPSA/LAMR1 and in turn facilitates the dephosphorylation of RPSA/LAMR1 (PubMed:16263087). Involved in the dephosphorylation of EEF1A1 (PubMed:26497934). {ECO:0000250|UniProtKB:Q8VHQ3, ECO:0000250|UniProtKB:Q95N27, ECO:0000269|PubMed:16263087, ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:25007873, ECO:0000269|PubMed:26497934}.
|Ank|
|Ank 2|
|negative regulation of peptidyl-serine dephosphorylation|
|regulation of peptidyl-serine dephosphorylation|
|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|
|regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|
|establishment of endothelial barrier|
|protein phosphatase regulator activity|
|positive regulation of sprouting angiogenesis|
|positive regulation of protein dephosphorylation|
|regulation of filopodium assembly|
|endothelial cell development|
|positive regulation of dephosphorylation|
|negative regulation of protein dephosphorylation|
|regulation of sprouting angiogenesis|
|endothelial cell differentiation|
|positive regulation of endothelial cell proliferation|
|endothelium development|
|cell projection|
|negative regulation of dephosphorylation|
|regulation of phosphoprotein phosphatase activity|
|regulation of phosphatidylinositol 3-kinase signaling|
|regulation of endothelial cell proliferation|
|regulation of protein dephosphorylation|
|positive regulation of angiogenesis|
|regulation of phosphatase activity|
|positive regulation of vasculature development|
|positive regulation of epithelial cell proliferation|
|epithelial cell development|
|regulation of plasma membrane bounded cell projection assembly|
|regulation of cell projection assembly|
|regulation of dephosphorylation|
|regulation of angiogenesis|
|regulation of vasculature development|
|regulation of epithelial cell proliferation|
|nuclear speck|
|negative regulation of phosphate metabolic process|
|negative regulation of phosphorus metabolic process|
|negative regulation of protein modification process|
|epithelial cell differentiation|
|regulation of plasma membrane bounded cell projection organization|
|perinuclear region of cytoplasm|
|regulation of cell projection organization|
|positive regulation of cell population proliferation|
|regulation of cellular component biogenesis|
|negative regulation of cellular protein metabolic process|
|regulation of anatomical structure morphogenesis|
|negative regulation of protein metabolic process|
|epithelium development|
|positive regulation of phosphate metabolic process|
|positive regulation of phosphorus metabolic process|
|positive regulation of protein modification process|
|regulation of hydrolase activity|
|positive regulation of developmental process|
|positive regulation of cellular protein metabolic process|
|regulation of cell population proliferation|
|cell development|
|positive regulation of protein metabolic process|
|positive regulation of multicellular organismal process|
|tissue development|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|-1.78|
|[[:results:exp538|ZLN024 50μM R08 exp538]]|2|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7200
* **Expression level (log2 read counts)**: 6.83
{{:chemogenomics:nalm6 dist.png?nolink |}}